RARA and hepatocellular carcinoma: However, the comparative growth-inhibitory studies performed in HCC-1599 cells with the above mentioned RAR agonists support the idea that RARβ contributes to ATRA-dependent growth inhibition in a ligand-independent manner (Figure 8G).